Answers are grounded in this paper and cite their sources.
Review compares strategies for site-specific modifications of proteins, highlighting innovation opportunities for biotherapeutics.
Site-specific modifications of native-sequence proteins are technologies that underpin progresses in chemical biology, diagnostics and next-generation biotherapeutics. However, the pursuit of site-specificity has often come at the expense of scalability and usability, ultimately limiting translational potential of a modification tool. This review critically compares current key strategies, including terminal, disulfide-rebridging, small-molecule, glycan and enzyme-based modifications. Finally, we present a decision tree for method selection and highlight opportunities for innovation in next-generation native-sequence protein modification technologies.
No takes yet. Share an insight, caveat, or question.
Angelastro et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: